obesity-995x60.png
FEATURED ARTICLES
Two Parallel Trials, A Potential New Option For Protection From COVID-19
Invivyd’s Michael Mina, MD, Ph.D., discusses LIBERTY and DECLARATION, exploring how monoclonal antibodies could expand COVID-19 protection alongside vaccines.
-
Firsthand Findings: How Incannex Is Designing Trials That Support Regulatory Approval
Incannex CEO Joel Latham explains how thoughtful trial design and dose optimization can turn promising data into an approval-ready strategy.
-
The Five Economic Risks Pharma Can't Treat As Background Noise
U.S. pricing reforms are already delaying drug launches abroad. See five economic risks facing pharma and why leaders across functions must plan together.
-
Lupus Researchers Now Have A Three-Pillar RWD Platform To Support Discovery And Development
Lupus Nexus unites a registry, biorepository, and data exchange to give researchers longitudinal real-world data without building the infrastructure from scratch.